Insights on Health Care

Gayland Hethcoat was featured in a Law360 Healthcare Authority Q&A on how the One Big Beautiful Bill Act (OBBBA) legislation is expected to significantly reduce state-directed payments in Medicaid managed care programs and impact hospitals, nursing facilities, and patients.

Investigations Partners Hillary Stemple and Nadia Patel will host a CLE webinar on how health care organizations’ compliance officers and general counsel can bolster compliance mechanisms in light of the re-launch of the Department of Justice and Department of Health and Human Services’ False Claims Act (FCA) Working Group.

Headlines that Matter for Companies and Executives in Regulated Industries

The Medicaid Drug Rebate Program (MDRP) Summit 2025 will be held in Chicago, IL, from September 15-17, 2025. This hybrid event is hosted by Informa Connect and will feature topics such as 340B, drug pricing policy, and the Inflation Reduction Act (IRA), designed to aid attendees in mastering complex regulatory guidelines.

Federal enforcement of information blocking rules has entered a new era.

Headlines that Matter for Companies and Executives in Regulated Industries

Headlines that Matter for Companies and Executives in Regulated Industries

In July, then-Chairman of the Energy and Commerce Health Subcommittee Rep. Buddy Carter (R-GA) announced that he would be “relinquish[ing] the gavel” to allow him to “put Georgians’ interests first.”

Headlines that Matter for Companies and Executives in Regulated Industries

Partner Hillary Stemple was quoted in Healthcare Risk Management on a Texas district judge’s decision vacating a 2024 rule that provided added protections under the Health Insurance Portability and Accountability Act (HIPAA) for reproductive health care information.

Counsel Gayland Hethcoat was quoted on the US Department of Health and Human Services Office for Civil Rights’ (OCR) Risk Analysis Initiative and its heightened enforcement of the Health Insurance Portability and Accountability Act (HIPAA) Security Rule risk analysis requirement to prevent data breaches.

Health Care Practice Leader Douglas Grimm was quoted on the growing interest among employers in direct primary care models and the financial predictability these models offer compared to traditional insurance.

Headlines that Matter for Companies and Executives in Regulated Industries

A North Carolina federal court’s recent order granting remand in the case Nash Hospitals, Inc. v. UnitedHealthcare of North Carolina, Inc., et al., No. 5:25-CV-28-FL underscores the limits of federal question jurisdiction in disputes arising from health care provider-payer agreements, particularly where the claims are grounded in state law and do not necessarily require resolution of a substantial federal issue.

ArentFox Schiff is pleased to announce that 132 attorneys have been recognized by The Best Lawyers in America 2026, with two attorneys highlighted as “Lawyers of the Year” and 66 attorneys listed as “Ones to Watch.”

On August 7, the US Department of Health and Human Services Office of Inspector General (OIG) issued Advisory Opinion No. 25-09, providing significant guidance for physician-owned medical device companies (PODs).

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Industry Group Co-Leader Annie Chang Lee was quoted on how hospitals and health care workers are vulnerable to potential raids by US Immigration and Customs Enforcement (ICE) following changes to federal policy regarding enforcement in sensitive locations.

Headlines that Matter for Companies and Executives in Regulated Industries

Food, Drug, Medical Device & Cosmetic Counsel Abha Kundi will deliver the opening presentation of the Healthcare Distribution Alliance’s (HDA) 2025 Traceability Seminar on August 5, 2025.

Headlines that Matter for Companies and Executives in Regulated Industries

On July 31, 2025, ArentFox Schiff hosted the HGPII Annual Best Practices Forum, one of the group purchasing sector’s premier training and leadership development conferences.

Immigration enforcement actions are no longer a theoretical concern for health care facilities — they are happening now.

Partner Emily Cowley Leongini was quoted on Sarepta Therapeutics’ decision to pause sales of its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec) following a request from the US Food and Drug Administration (FDA).

Every July, the Centers for Medicare & Medicaid Services (CMS) publishes two proposed rules that set Medicare reimbursement and shape the administration of the Medicare Part B program for the upcoming calendar year. These rules are the Physician Fee Schedule (PFS) proposed rule and the Hospital Outpatient Prospective Payment System (HOPPS) proposed rule.